Ver-A-DM1

N/A

Report date: 2022/04/18 13:49:24

Base Information

Drug NameVer-A-DM1
Drug Alias Nameverrucarin A+mertansineverrucarin A-mertansineVer-A/DM1Ver-A/DM-1Ver-A-DM1 +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunologic cytotoxicityTubulin depolymerization inhibitors
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama At Birmingham
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Alabama At Birmingham
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A